Life Science Washington
2025-26
HB 1062 - Biomarker testing coverage π1
HB 1238 - Rare diseases adv. council π1
HB 1444 - Whole genome sequencing π1
HB 1725 - Biosimilar medicines π1
HB 2100 - Enacting an excise tax on large operating companies on the amount of payroll expenses above the minimum wage threshold of the additional medicare tax to fund services to benefit Washingtonians and establishing the Well Washington fund account. π1
HB 2145 - 340B drug pricing program π2
- ππ΅ Curtis Knapp
- ππ΅ Curtis Knapp
HB 2542 - Animal testing alternatives β1
SB 5064 - Rare diseases adv. council π2
SB 5400 - Local news journalism π1
SB 5455 - Cancer research endowment π3
SB 5594 - Biosimilar medicines π1 π1
SB 5813 - Tax rates/cap. gains, estate π1
SB 5815 - Modifying business and occupation tax surcharges, rates, and the advanced computing surcharge cap, clarifying the business and occupation tax deduction for certain investments, and creating a temporary business and occupation tax surcharge on large companies. π1
SB 5915 - Health technology assessment π1
SB 5981 - 340B drug pricing program π2
- ππ΅ Curtis Knapp
- ππ΅ Curtis Knapp
2023-24
SB 5981 - 340B drug pricing program π2
- ππ΅ Curtis Knapp
- ππ΅ Curtis Knapp
HB 1269 - Rx drug affordability board π1
HB 1374 - Office of career connect WA π1
HB 1450 - Biomarker testing coverage π3
HB 1745 - Diversity in clinical trials π1
SB 5074 - Biomarker testing coverage π1
SB 5097 - Rare diseases adv. council π2
SB 5388 - Diversity in clinical trials π1
SB 5911 - Cancer research funding π1
Created by @tannewt. Contribute
on GitHub.